Clinical trial
Evaluation of Immune Cell Subgroups in Covid 19 Patients
NCT04531319 is registered in ClinicalTrials.gov with Istanbul Training and Research Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Immune Cell Subgroups in Covid 19 Patients
- Lead sponsor
- Istanbul Training and Research Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- August 15, 2020
- Completion date
- October 1, 2020
- Enrollment
- 50 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
covid19